Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector.
The investigation focuses on potential breaches of data privacy laws and the importation of unlicensed cancer medications.
CEO Pascal Soriot said AstraZeneca is compliant with Chinese policies and is working closely with authorities following the detention.
The probe centers around AstraZeneca’s eight or nine employees, Soriot said in a Bloomberg TV interview, noting that the firm employs 12,000 people in the country. It’s “impossible” for every employee to act as a compliance officer, Soriot added.
Also Read: AstraZeneca ...
